Furthermore, it inhibits EMT and cancer stem cell formation in breast cancer cells to halt metastatic recurrence by disrupting TGF-β1-mediated interactions between TAMs and breast cancer cells [448]. This evidence concerns the gene TGFB1 and breast carcinoma.